Verrica Pharmaceuticals(VRCA)
$3.56-0.16 (-4.30%)
VRCA
Verrica Pharmaceuticals earnings date
$3.56
At close:-0.16 (-4.30%)
Want to see VRCA full AI Analyst Report?
Verrica Pharmaceuticals (VRCA) Q2 2024 Earnings Report
490 Followers
VRCA Q2 2024 EPS Results
- Actual EPS
- -$3.70
- Consensus EPS
- -$4.14
- Beat/Miss
- Beat by +$0.44
- One Year Ago EPS
- -$2.40
VRCA Q2 2024 Revenue Results
- Actual Revenue
- $5.18M
- Expected Revenue
- $4.58M
- Beat/Miss
- Beat by +$594.00K
- YoY Revenue Growth
- +2744.51%
Earnings Announcement Details
- Quarter
- Q2 2024
- Date
- 08/14/2024
- Time
- Before Open
- Conference Call
- Wednesday, August 14, 2024
VRCA Upcoming Earnings
Verrica Pharmaceuticals's next earnings date is estimated for March 4, 2027, based on past reporting schedules.
Q2 2024 Earnings Call Audio
VRCA Q2 2024 Earnings Call
0:00 / 0:00
Q2 2024 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2024 Earnings Call Summary
No earnings call summary is available for this earnings event.
VRCA Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 04, 2027 | 2026 (Q4) | -0.52- | -0.57 | ― | ― |
| Nov 12, 2026 | 2026 (Q3) | -0.50-0.58 | -0.03 | -1833.33% (-0.55) | |
| Aug 06, 2026 | 2026 (Q2) | -0.39-0.62 | 0.02 | -3200.00% (-0.64) | |
| May 12, 2026 | 2026 (Q1) | -0.36-0.45 | -1 | 55.00% (+0.55) | |
| Mar 11, 2026 | 2025 (Q4) | -0.79-0.57 | -2.4 | 76.25% (+1.83) | |
| Nov 14, 2025 | 2025 (Q3) | -0.06-0.03 | -4.9 | 99.39% (+4.87) | |
| Aug 12, 2025 | 2025 (Q2) | -0.700.02 | -3.7 | 100.54% (+3.72) | |
| May 13, 2025 | 2025 (Q1) | -1.23-1.00 | -4.4 | 77.27% (+3.40) | |
| Mar 11, 2025 | 2024 (Q4) | -2.52-2.40 | -5.3 | 54.72% (+2.90) | |
| Nov 04, 2024 | 2024 (Q3) | -3.76-4.90 | -5.4 | 9.26% (+0.50) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed

